Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 23, Issue 3, 2005, Pages 200-207

  Kocak, Zafer ^a,e   Ozkan, Hasan ^b   Adli, Mustafa ^c   Garipagaoglu, Melahat ^d   Kurtman, Cengiz ^b   Cakmak, Ahmet ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

^d AKDENIZ UNIVERSITY   (Turkey)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bile duct tumors; Brachytherapy; Palliation; Radiation; Stenting

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRIDIUM 192;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILE DUCT TUMOR; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CHOLANGITIS; CLINICAL ARTICLE; DEVICE; DUODENUM ULCER; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER ABSCESS; MALE; OBSTRUCTIVE JAUNDICE; PAIN; PRURITUS; RADIATION DOSE; STENT; TREATMENT OUTCOME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; CONSTRICTION, PATHOLOGIC; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 21044442904     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg, 194: 447-457, 1981.
2. Erickson BA, Nag S. Biliary tree malignancies. J Surg Oncol; 67: 203-210, 1998.
3. Montemaggi P, Costamagna G, Dobelbower RR, et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys, 32: 437-443, 1995.
4. Mayer R, Stranzl H, Prettenhofer U, et al. Palliative treatment of unresectable bile duct tumours. Acta Med Austriaca, 30: 10-12, 2003.
5. Leung J, Guiney M, Das R. Intraluminal brachytherapy in bile duct carcinomas. Aust N Z J Surg, 66: 74-77, 1996.
6. Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys, 57: 105-112, 2003.
7. Bruha R, Petrtyl J, Kubecova M, et al. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - the question of long-term palliation. Hepatogastroenterology, 48: 631-637, 2001.
8. Fritz P, Brambs HJ, Schraube P, Freund U, Berns C, Wannenmacher M. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys, 29: 855-861, 1994.
9. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg, 82: 1522-1525, 1995.
10. Eschelman DJ, Shapiro MJ, Bonn J, et al. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined modality radiation therapy. Radiology, 200: 717-724, 1996.
11. Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys, 34: 767-774, 1996.
12. 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys, 57: 1357-1365, 2003.
13. Tamada K, Sugano K. Diagnosis and non-surgical treatment of bile duct carcinoma: developments in the past decade. J Gastroenterol, 35: 319-325, 2000.
14. Greene FL, Page DL, Fleming ID, et al. Extrahepatic bile ducts. American Joint Committee on Cancer. In AJCC Cancer Staging Manual, 6th ed. (Springer New York, NY), pp. 145-150, 2002.
15. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-1346, 1995.
16. Conroy RM, Shahbazian AA, Edwards KC, et al. A new method for treating carcinomatous biliary obstruction with intracatheter radium. Cancer, 49: 1321-1327, 1982.
17. Kim GE, Shin HS, Seong JS, et al. The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma. Int J Radiat Oncol Biol Phys, 28: 711-717, 1994.
18. Erickson B, Nag S. Extrahepatic bile duct cancer and liver cancer. In Principles and Practice of Brachytherapy, 1st ed. (Nag S ed.; Futura Publishing Co, New York, NY), pp. 367-391, 1997.
19. Kurisu K, Hishikawa Y, Taniguchi M, et al. High-dose-rate intraluminal brachytherapy for bile duct carcinoma after surgery. Radiother Oncol, 21: 65-66, 1991.
20. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut, 39: 852-855, 1996.
21. 192iridium wire. Br J Surg, 70: 733-735, 1983.
22. Karani J, Fletcher M, Brinkley D, Dawson JL, Williams R, Nunnerley H. Internal biliary drainage and local radiotherapy with iridium-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol, 36: 603-606, 1985.
23. Gonzalez Gonzalez D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol, 10 (Suppl 4): 215-220, 1999.
24. Lameris JS, Stoker J, Nijs HG, et al. Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology, 179: 703-707, 1991.